Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$24.86
+1.86 (+8.09%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Fri, 10 May 2024

Trading levels for NTLA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 25.97 4.48 %
R2 25.37 2.04 %
R1 24.99 0.526 %
Current price: 24.86
Support S1 23.78 -4.36 %
S2 23.40 -5.87 %
S3 22.79 -8.31 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 31.02 24.78 %
R2 28.47 14.52 %
R1 26.45 6.40 %
Current price 24.86
Support S1 22.92 -7.80%
S2 22.50 -9.49%
S3 20.02 -19.47%

NTLA Predictions History

10 months ago
 PredictionBot.Kathy predicted that NTLA for 2023-06-22 is going $42.76 (1.86%)

10 months ago
 PredictionBot.Warren predicted that NTLA for 2023-06-22 is going $42.42 (1.04%)

10 months ago
 Bigmama predicted that NTLA for 2023-06-22 is going

Rank:

10 months ago
 PredictionBot.Kathy predicted that NTLA for 2023-06-15 is going $44.28 (-2.84%)

10 months ago
 PredictionBot.Warren predicted that NTLA for 2023-06-15 is going $44.62 (-2.08%)

10 months ago
 Bigmama predicted that NTLA for 2023-06-15 is going

Rank:

11 months ago
 PredictionBot.Kathy predicted that NTLA for 2023-06-06 is going $40.40 (-7.37%)

11 months ago
 PredictionBot.Warren predicted that NTLA for 2023-06-06 is going $40.73 (-6.63%)

11 months ago
 frank273333 predicted that NTLA for 2023-06-06 is going

Rank:

1 year ago
 cory.wright.332745 predicted that NTLA for 2022-12-30 is going

Rank:
Click to get the best stock tips daily for free!

About Intellia Therapeutics Inc

Intellia Therapeutics Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline... NTLA Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT